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1.0

Executive Summary

The goal of this project was to build an in-vitro model simulating blood flow through
the brachial artery by using synthetic tubing to resemble varying levels of endothelial
plaque buildup. This model will allow for a hemodynamic analysis of flow profile by
modeling pressure and flow waveforms that would normally be obtained via a blood
pressure cuff.
This model was required to be functional and compact, under 6 square feet. It needed
to use test tubing that had similar compliance to arteries, between 1.0 and 1.7
ml/mmHg. The flow rate needed to be between 300 to 500 ml/min and flow
intermittently with 0.5 seconds on and 0.3 seconds on. Through these requirements
the pressure ranges measured across the sample were to be within physiological
constraints of 80 to 200 mmHg, relating to the low end of diastolic and a high systolic
blood pressure respectively.
Through testing of the final prototype these requirements were achieved, and the
data obtained from these flow profiles with varying synthetic tubing was used to
further explain the relationship between shear rate of blood flow and subclinical
atherosclerosis. We hope that the information gathered from this model can one day
lead to a minimally invasive medical device that can detect arterial plaque buildup in
patients.

2.0

Statement of Work
Abstract

This Statement of Work covers the design and manufacturing of the Cumulative
Shear In Vitro Model. The following document contains information on the project
background, importance of the product, objects, key deliverables, and project
management plan.
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Introduction
The goal of our model is to find a reliable method of subclinical atherosclerosis
detection by measuring the pressure drop across an artery. Using this, the internal
roughness of the artery tubing can be calculated. The roughness will be verified using
confocal microscopy. This value will lead to a set range of flow values wherein
laminar flow becomes turbulent in arteries, causing shear rate to drastically
decrease. As this decrease is ultimately related to atherosclerosis, early detection
could prove life saving for millions of patients worldwide. Successful execution of this
in vitro model could lead to the development of a medical device that could
noninvasively detect subclinical atherosclerosis.

Background
Atherosclerosis is a buildup of plaque between the layers of arterial walls. It’s
a prevalent disease in the U.S., with 3 million cases diagnosed annually; with today’s
methods, it’s difficult to detect. Arterial endothelial cells require a threshold shear
rate to release nitric oxide, allowing for vasodilation. Plaque inhibits this, causing
stiff arteries that are prone to disease. Accurate pressure drop measurement across
an artery is key for early diagnosis of atherosclerosis, as it allows for determination of
corresponding cumulative shear rate and endothelial cell function level. (Refer to
Intellectual Property Assessment)

Objectives
This project aims to develop an In Vitro model that has the ability to quantify
the effects of parameters on cumulative shear. It includes an enclosed chamber that
can hold pressure, tubing system, test samples modeling arterial plaque buildup,
bucket to hold water for the system, pump, and a Biopac and computer to measure
pressure differences. The customer requires the device to be compact, output
accurate values within physiological ranges, be cost effective and be able to
withstand multiple uses. (Refer to Product Specifications Matrix)
The cost will be measured by the overall cost of material. To keep the model
compact we will test different setups of the model and measure the space it takes up
in cubic feet. We will test the efficiency of different sample materials and look at the
output ranges to check if it is within physiological values. We will run continuous tests
to measure the accuracy of the device and compare the devices output with known
accurate values. The level of knowledge required will be measured based on the
equipment needed to measure the pressure values. We will program the pump to
either give continuous or intermittent waveforms and measure the effect of the
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waveforms on output values. The accessibility will be measured based on if it can be
opened and resealed again to change test samples.

Project Management
The design process we will follow will include project planning, product
definition, conceptual design and product development. Project planning includes
creating a PERT chart, identifying the critical path, and creating a budget. Product
definitions gathering customer requirements and determining product engineering
specifications. The conceptual design phase includes generating and evaluating
product designs, choosing a final design and refining it to match customer needs. The
product development phase will include creating the product, performing tests with it
and making final changes. (Refer to Network Diagram)
The next step in the design process is to create conceptual design ideas based
on our customer feedback analysis and refine the final design choice. Later we will
obtain roughness ratings on samples using confocal microscopy, determine value of
pressure drop indicating turbulent flow in a vessel and modify the model to include
test samples within physiological ranges.
The Program Evaluation Review Technique chart includes three main phases:
concept design, product development and post development analysis. Each phase
must be completed before we can move on to the next phase of the project. Our
critical path included the following deliverables: project budget, materials research,
refine current design, develop schematic model, preliminary design review, concept
design presentation, adjust variables to be within physiological ranges, function
prototype, measure roughness with confocal microscope, calculate data from Biopac
results and create final presentation and poster.

Conclusion
This project is mainly to quantify the effects of cumulative shear on arteries
and its relation to predicting a major cardiovascular event. This document outlines
the necessary components to execute the project. The next steps are to develop a
schematic of the in vitro model and prepare for the preliminary design review.
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3.0

Network Diagram
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4.0

Indications for Use

Our Cumulative Shear In-Vitro Model is indicated to better define the relationship
between shear rate and how it relates to endothelial dysfunction to better predict
Subclinical Atherosclerosis in patients with asymptomatic or potential heart disease.
The information gathered from our Cumulative Shear in Vitro Model could lead to a
medical device indicated for use in patients who are judged by a cardiologist or heart
specialist to possibly be in the early stages of Subclinical Atherosclerosis and as a low
risk and minimally invasive means of detecting arterial plaque buildup or blockage to
further evaluate the patient.

5.0

Budget

The total cost of our project was approximately $110 after all necessary
purchases. In our budget, we did not list the pump at first for two reasons: it can be
extremely expensive for a pump sufficient for our experiment and we already have a
functioning pump (although it may cause issues after a waveform generator is
incorporated). This has changed, as a sponsor for a project that will begin after ours
has purchased the pump for our project. The flow meter has been listed as $40 on our
budget but was not purchased; in order to obtain the accuracy required in our
specifications, we would need to spend upwards of $100 just to achieve a range of
+/- 5%, which can also be obtained by manually measuring the flow rate.
7

Customer Requirements

6.0

1. Design a functional in vitro model
2. Create models of brachial artery with plaque buildup that is similar to artery
compliant
3. Make model more compact and functional
4. Control flow rate and waveform timing
5. Obtain values within physiological constraints
6. Explain and define relationship between shear rate and endothelial dysfunction
7. Use confocal microscope to measure roughness in sample tubes

Specification Development

7.0

Our major engineering specifications are outlined and quantified below:
Spec #

Parameter
Description

Requirements or
Target (units)

Tolerance

Risk

Compliance

1

Accuracy
(ΔPressure)

± .1 PSI

N/A

H

T, A, I

2

Flow Rate

400 ml/min

± 100.0

M

T

3

Pressure in
Chamber

3.48 PSI at
Systole

± .2 (blood
pressure varies
significantly)

L

A, I

2.32 PSI at
Diastole
4

Size (Overall)

2
6 ft

Max.

L

S, I

5

Weight (Overall)

20lb

Max.

M

T, A, S

6

Production Cost

$200

Max.

L

A

8

7

Sample
Compliance

1.775 ml/mm
Hg (Normal)

± .5

H

T, A

1.072 ml/mm
Hg (Diseased)
8

Intermittent Flow
Timing

.5s off
(diastole), .3s
on (systole)

± .05

M

T

9

Pressure Ranges

80 mmHg to
200 mmHg

N/A

L

T, I

Risk: H (high), M (medium), L (low)
Compliance: T (test), A (analysis), I (inspection), S (similarity)

8.0

Total Available Market and
Competitive Advantage Matrix

There are currently 28.2 million diagnosed with cardiovascular disease, and
about 647,000 people die from cardiovascular disease each year; this is the highest
cause of death in the US.
Assuming a unit price of $2000 for current models (see Competitive Advantage
Matrix) and considering there are only about 6200 active hospitals in the US currently
(each hospital may have 8 models), the total market would be about $99.2 million.
Since this market is based on models sold to hospitals, room for growth is not as easily
accounted for and could change abruptly based on many factors.
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Itamar and Endothelix are compared to the Cumulative Shear In-Vitro model,
which is in the stages of being modeled and therefore many features have yet to be
determined. Once the final stages of design are completed and the model moves into
the phase where it is converted to a commercial product, these features will be
implemented.

9.0

Intellectual Property Assessment
Major Patent Results for Existing Designs to Note:

System and method for estimating arterial pulse wave velocity (10,438,355): A
method of determining arterial pulse wave velocity in a healthy artery utilizing
imaging modality.
Assignee: General Electric Company (Schenectady, NY)
Cardiac Simulation Device (10,229,615): A device that uses pressurized chambers to
generate ventricle and atrium contractions. This invention is designed to generate
pumping action that produces accurate volume fractions and pressure gradients of
pulsatile flow, similar to that of the human heart.
Assignee: Vascular Simulations Inc. (Wilmington, DE)
Physiological signal stimulator and simulator (10,067,489): An apparatus that
receives programming values in order to generate electrical signals similar to the
heart.
Assignee: COMMISSIONING AGENTS, INC. (N/A)
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10.0

Conjoint Analysis

The factors that are important to the success of the product based on the
ANOVA results are
●
Cost
●
Compactness
●
Accuracy
●
Container accessibility
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11.0

Morphology
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12.0

Concept Evaluation

Concept 1:

This concept uses clamps to open and close lid with an O-ring to ensure it holds
pressure. A syringe would be used to add or release air to control the pressure of the
chamber. The sample tubing is secured to the system tubing with zip ties to endure a
tight fit.
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Concept 2:

This concept utilizes silicone sealant to effectively seal lid to chamber and maintain
pressure. The sealant is removed by a compound that dissolves it when lid needs to be
opened. A hose clamp is used to clamp the tubing and hold it to chamber wall.
Pressure is increased or decreased via a manual hand pump.
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Concept 3:

This concept uses wingnuts to ensure seal against O-ring for maintaining pressure
within the chamber. The lid would have handles for easy placement and lifting, while
middle of lid has a connection to pressure transducer/hand pump to alter and
measure pressure inside the chamber. The wingnut with O-ring design prevents any
pressure leak due to threaded connection.
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13.0

●
●

Pugh Matrix

Analysis of the Pugh Chart shows concept design #3 to be the most effective
It allows for a highly accessible, securely fastened chamber with little chance
of pressure or water leaks
The feasibility and compliance with physiological characteristics are average,
but the other designs are not much better in either regard

●

14.0

Front Runner

● Plexiglass chamber with an O-ring sealing mechanism (wing nut design) on top
to allow for changing samples
○ Pressure in chamber changeable through syringe in front of chamber
○ Hand pump on top of the lid to change compliance
○ Pressure transducer on top of lid
○ Samples will be thin-walled rubber tubing
○ Cost of Chamber: $56.93
● Diaphragm pump to pump water through chamber
○ Cost of Generator and Pump: $1,100 - obtained from sponsor so not
included in budget
16

● Water flows into graduated cylinder, volume over time is calculated to
determine flow rate
○ Cost of Flow Measurement: $0
Dimensioning:
●

Chamber
○
6” x 6” x 10”
○
Lid will be 4.5” diameter

●

Overall System
○
4ft²
○
Compact, mobile design

Total Cost: $56.93

Conceptual Model

15.0

CAD Design:
Isometric View

Front View

Note: Front of chamber removed in drawings for visual purposes. Front panel will be
identical to the back panel and sealed in place.
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Top View

Side View

Schematic of Total System:

Schematic of Total System:
●

Waveform Generator to control pump
18

●
●
●
●

Pump drives water flow through samples
Pressure driven via diaphragm pump
Pressure Transducer takes pressure drop readings
Flow Meter to measure flow rate

Mathematical Model

16.0

Darcy’s Equation:

For our model, we can assume z1,

v2
1

2g

, hA, hR, z2 and

v2
2

2g

are equal to 0.

Darcy’s equation can be used to calculate head loss. Head loss (hl) is a loss in
pressure head due to the viscosity of a fluid and obstructions of flow.
In this calculation the following assumptions are made:
1. No energy is added to the system therefore hA = 0.
2. No energy is returned therefore hR = 0.
3. The elevation of both pressure transducers is equal therefore z1 = z2.
4. The flow is incompressible and the diameters at each end of the tube are equal
therefore v1 = v2.
5. Head loss can then be calculated by the difference in pressures over the
specific weight of the fluid.

Energy Loss:
hL = f × DL ×

v2
2g

‘f’ is the friction factor of a sample and is used to determine turbulent versus laminar
flow on a Moody diagram. Solve for linear velocity ‘v’ with equation for flow rate
19

from the continuity equation:

Q = Av
Once linear velocity is determined using the flow rate equation, the friction factor
can be calculated.
Reynold’s Number:

NR =

ρvD
μ

The Reynold’s number can then be calculated using the density, fluid velocity,
inner tube diameter, and dynamic viscosity.
The Reynold’s number and friction factor then allows us to use a moody diagram via
triangulation to determine laminar vs turbulent flow and then estimate shear rate.
Greater energy losses and lower shear rate corresponds to turbulent flow.
Compliance:

Compliance is used to determine how similar our sample tubing is to a human brachial
artery; on average, a healthy brachial artery has a compliance of approximately 1.775
ml/mmHg and a diseased artery has a compliance of approximately 1.072 ml/mmHg.
After calculating the compliance of the tubing we used for samples, we determined
that the compliance of a healthy sample (no added material) was around 1.240
ml/mmHg (30% difference) and the compliance of a diseased sample was around .8976
ml/mmHg (16.2% difference).
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17.0

Detailed Design

Dimensioned Tubing:

Isometric of Design:

Front View of Design:
21

Side View of Design:

Materials
● Chamber: Plexiglass walls and lid, brass bolts, rubber O-ring, rubber tubing
(top of chamber), silicone caulk for sealant
● Sample: Pig artery, rubber tubing
22

● Total Cost: $56.93
Dimensions
● Sample Tubing: ¼” inner diameter, 1/32” wall thickness
○ Pig arteries are similar but not exact
● Chamber: 6” tall, 6” wide, 10” long
○ ¼” diameter holes drilled at center of each end (samples)
○ ¼” diameter hole drilled at center of one of the long panels, located 1”
above the base (syringe)
● Lid: 4.5” diameter
○ .5” radius semicircles extended on both sides parallel to sample tubing
in chamber
○ ⅜” holes drilled/tapped for wing bolt placement in center of semicircles
○ ¼” hole drilled through center of lid (tubing)

Bill of Materials

18.0

Quantity Part Description

Part Number

Source

CHAMBER
7

Acrylic

8560K275

McMaster Carr

1

Acrylic Cement

10315

Amazon

2

Brass Wing-nuts

99862A520

McMaster Carr

1

Bolt Adhesive

1452853

Dr. Whitt

1

Rubber Sheet

203193498

Home Depot

2

10/32 E-Z Lock
Inserts

240-332-BR

E-Z Lock

200382AFA

Amazon

SYSTEM
1

Signal
Generator
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2

Sample Tubing

5234K98

1

Water Storage

N/A

1 pack

¼” Male Fittings AO-45505-19

McMaster Carr

1 pack

¼” Female
Fittings

AO-45505-20

McMaster Carr

1

NF100
Liquiport pump

112021043

KNF

19.0

1.

2.

3.
4.
5.

McMaster Carr

Prototype Manufacturing Plans
Chamber Manufacturing
Each of the 7 acrylic pieces (#8560K275) need to be cut to size using a laser
cutter
a. 2 6” x 6” pieces with ¼“ radius holes centered
b. 3 6” x 8” pieces
c. 1 6” x 8” piece with a 4.5” diameter circle cut out of the center
d. 1 4.5” circle with 2 0.5” circular sticking out on either side as shown in
the detailed CAD drawing. In the circular lid a ¼“ radius hole is cut from
the center
The chamber is assembled with the acrylic cement (#10315) to connect the
plexiglass pieces at the edges to put together the chamber as shown in the
detailed design CAD drawing.
Male fitting (#AO-45505-19) connected to a female fitting (#AO-45505-20) are
secured with the sealant into the holes of the 6” x 6” pieces at their center.
Rubber sheet (#203193498) is cut to the size of the lid and holes are cut in
same place as on lid
2 ¼ inch holes are drilled in the top directly across from each other of the
circle and the E-Z lock inserts (#240-332-BR) are gently hammered into place so
that they are flush with the top of the chamber

Sample Tubing Manufacturing
1. Sample Tubing (#5234K98) is cut to 7” piece
2. Epoxy or gorilla glue is inserted into one end and spread throughout the tube
using a long metal rod
24

3. The rod is dipped into substance (i.e. sand or glitter) and pushed through the
tube again rubbing it against the edged
4. This is repeated at the other end of the tube and can be done multiple times to
increase the amount of substance lining the walls of the tube

1.
2.
3.
4.
5.

20.0

Connecting Entire System
Tubing is connected to the outlet of the chamber and then a pressure
transducer that connects to the Biopac is placed
Tubing is connected to the other side of the pressure transducer and the flow
meter which is connected with tubing to the water source
From the water source comes more tubing which connected the system to the
pump, which is connected to the waveform generator via wires
The system is completed by attaching the other end of the pump with another
pressure transducer to the inlet
Pressure transducers (including one on top of the chamber) are all connected
to channels of the Biopac, which displays data on the computer system

Test Protocols

We will need to test the chamber to make sure it is properly sealed. We will fill the
chamber with water and check for leaks in the sealant between the plexiglas pieces.
It will be easy to tell if water is leaking from the chamber immediately and we will
reseal areas needing attention. To test if the chamber can hold pressure, we will
pressurize the chamber with the hand pump. We will check if the chamber holds
pressure using the pressure transducer on the lid. It needs to maintain a pressure of
at least 200 mmHg. Once the chamber passes the water and pressure test, we can
move on to testing arterial samples.
We will also need to ensure the tubing throughout the entire system does not leak
water, specifically where fittings are connected to the tubing. We will be able to
visibly see any leaks. If tests fail, we will replace fittings, add sealant and try again.
The flow rate must be within the range of 400 ml/min ± 100. This will be read by the
flow meter and we can alter the pump until we are within this range.
To test arterial samples, the sample will be attached to the fittings on the sides of
the chamber using dental floss. The chamber will be filled with water, the lid will be
25

secured with the wingnuts and the chamber will be pressurized. We will start the
pump for the liquid to be pumped through the system and record the pressure
difference using the Biopac. The pressure drops will be recorded for one minute.
Recorded pressure needs to be in physiological ranges between 50 and 200 mmHg. In
order to obtain this, we will adjust chamber pressure in increments of 5 mmHg. If
physiological ranges are still not recorded, then we will change arterial samples.
To determine Relative roughness of sample material inside arteries the last confocal
microscope will be used. This experimentally determined surface roughness can then
be utilized to confirm hand calculations. This test will be conducted by gluing various
samples (sand and glitter) to a microscope slide and setting the microscope to the
proper settings. Photons are emitted from the microscope and are then reflected
back creating a 3-d topographical map. The surface roughness is then determined
from the relative area of this map.
All testing will be done in the ATL building and imaging room, no special training is
required. We will be using the whole system, including the Biopac, chamber, tubing,
and sample arteries.

21.0

Operations Manual Overview

SYSTEM
● Pressure transducers must be flushed with water (removing the cap and letting
water flow through) to accurately read pressure
● Chamber filled with water to control compliance of system
● Lid is taken off by two wing-bolts located on top of chamber; once removed,
samples may be inserted into the two fittings on either side. Once replaced,
seal lid with O-ring and ensure that it is airtight
● To increase the pressure in the chamber, twist the luer lock for the syringe to
close and take the syringe off; fill with air, put the syringe back on and open
the luer lock.
PUMP
● The pump mechanism is controlled by a battery pack; turn the switch to ‘on’ to
begin pumping
26

● After incorporation, the waveform generator will be the connection between
the battery pack and pump. Set desired duty cycle and frequency to control
square wave.

22.0

Testing Data and Analyses

Test 1

Test 1

Test 2

Test 2

Sample

Friction Factor

Shear Rate

Friction Factor

Shear Rate

1 - Sand

0.055456177

394.4892953

0.057340765

393.3589535

2 - Sand

0.079565334

441.9636517

0.081328045

421.617499

3 - Sand

0.049393655

291.6281896

0.049156699

375.2734843

4 - Sand

0.060233866

376.4038262

0.063700281

366.2307498

5 - Glitter
(fine)

0.050619973

362.8397243

0.042041298

368.4914334

6 - Epoxy

0.034095404

377.534168

0.024773771

361.7093825

7 - Baseline 1

0.029894883

367.3610916

0.031126433

367.3610916

8 - Baseline 2

0.032115608

358.318357

0.029416093

359.4486988

9 - Glitter 1
(Chunky)

0.03241938

310.8440006

0.032208358

311.9743424

10 - Glitter 2
(Chunky)

0.121030608

394.4892953

0.097220727

397.8803207
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The first image is a Moody Diagram; by obtaining Reynold’s Number and the friction
factor of a given sample, we are able to determine whether the flow through the
sample is laminar or turbulent. In all 10 samples, we found that the flow was laminar,
and were therefore able to use the equation

to determine the shear rate of each sample. As seen in the table, the shear rate
somewhat correlated with an increase in friction factor; since the equation does not
account for head loss in the system, however, the friction factor has a much better
correlation with pressure drop within the samples. In the second image, all 10
samples are placed within the laminar flow region of the Moody Diagram. Since each
sample was tested twice, #1 and #2 are for Sample 1, #3 and #4 are for Sample 2, etc.

23.0

Conclusions

Using Darcy’s equation and energy loss, we were able to calculate the friction factor
from the pressure differences obtained in our tests. We were able to see that friction
factor increased with the addition of sand or glitter material in relation to the
baseline reading. This is obtained from the pressure readings suggesting that this
factor can be measured noninvasively with a pressure cuff in a future device.
We can also relate this friction factor to the shear rate of an artery. By using a moody
diagram, we were able to determine if it is laminar or turbulent flow. Based off of
this we can use the appropriate shear rate equation to establish a relationship
between pressure and flow. It is known that low wall shear stress correlates to
abnormal flow in a tube.
In conclusion, our data shows a significant increase in both friction factor and relative
roughness of our synthetic tubing when compared to baseline, which can ultimately
lead to subclinical atherosclerosis.
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24.0

Discussion

While the data obtained from this model is highly useful, for future testing creating a
more physiologically accurate model would be critical to getting the most accurate
results. Both arterial compliance and material properties of our synthetic arteries
could be improved to better model human arterial hemodynamics. While our arterial
compliance values were within tolerance, interpretation of data should be guarded as
this was the best compliance, we could obtain using synthetic arteries. Continuation
of this in-vivo model should use animal or human arteries to give the most accurate
physiological waveforms possible when analyzing data. Further, the fluid running
through our model was water. Using a fluid similar to that of the viscosity of blood
would provide for more accurate flow profiles for hemodynamic analysis.
Being able to validate our hand calculated relative roughness with some kind of
measurement was something we were unable to do. We attempted to quantify surface
roughness by using a confocal microscope to calculate relative area as this was the
best resource available to us at Cal Poly. However, a number of issues presented
preventing testing ranging from mounting of samples to particulates falling into
microscope made it infeasible to image samples. A different method to quantify
roughness should be considered to provide validation to the accuracy of calculated
surface roughness values.
Lastly, in this in-vitro model sand, glitter, and silicone epoxy were utilized to
simulate arterial plaque. While these materials are useful to look at varying levels of
roughness affect rate of shear, using a material that better resembles a calcified
region of artery would allow for a more accurate comparison between blood flow
shear rate changes and arterial plaque build up. While the results of our testing show
that this relationship is present, improving physiological parameters would for a more
accurate analysis as the wall shear stress generated from blood flow would be
modeling endothelial dysfunction more accurately than our current design.
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